China Angelman Syndrome Therapeutics Market Size, Competitive Landscape, Regional Outlook and Driving Factors Analysis 2028

Report Overview

China Angelman Syndrome Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Angelman is a rare genetic disorder that is characterized by developmental delay, severe speech impairment, seizures, and movement and balance disorders (ataxia). Angelman syndrome affects males and females in equal numbers. The global prevalence of Angelman syndrome is estimated to be approximately 1 in 12,000-20,000 people. As of now in China nearly 1000 children with Angelman syndrome have been registered across the country. In China, Angelman syndrome affects males and females in equal numbers.

Market Drivers

China is a growing market for Angelman syndrome due to an increase in the global prevalence rate (1 in 12,000-20,000 people) and increase in R&D activities. In addition to these, other factors that contribute to the growth of the market are increase in awareness of the disease and increase in healthcare expenditure towards rare disease drug development.

However, there are some restraining factors for growth of Angelman syndrome therapeutics market in China such as misdiagnosis, underdiagnosis and lack of novel therapeutics.

Get Exclusive Free Sample Report @ https://www.prudentmarkets.com/sample-request/139809/

Major Players

Some of the key players in the China Angelman syndrome therapeutics market are Ovid Therapeutics Inc; Hong Kong Angelman Syndrome Foundation (HKASF); H. Lundbeck A/S; Sarepta Therapeutics.

Key players are adapting various strategies such as distribution partnership, collaboration and licensing agreement to increase the product awareness and market share of the product. For instance, Lundbeck and Ovid Therapeutics Announce Exclusive Worldwide Licensing Agreement for Gaboxadol, and it is used for treatment of Angelman syndrome.

The report delivers the challenges in front of the China Angelman Syndrome Therapeutics Market 2023 that allows a better understanding of the market providing a helpful comprehensive evaluation and clear-cut dynamics associated with this market. The analyst has studied the current market scenario while concentrating on the new business objectives with the lucrative opportunities that are available. This report includes changes in customer requirements, customer preferences, and the vendor landscape in the industry with key factors that are expected to influence the overall dynamics of the China Angelman Syndrome Therapeuticss Market including the current trends, growth opportunities, restraints, and market drivers.

To Know More About COVID-19 Impact On China Angelman Syndrome Therapeutics Market @ https://www.prudentmarkets.com/sample-request/139809/

Market Segmentation

By Therapy:

On the basis of therapy, the China Angelman syndrome therapeutics market can be segmented into behavioural therapy, communication therapy, occupational therapy and physiotherapy.

Angelman syndrome can cause a number of behavioural issues, including hyperactivity, aggressive behaviour, sleep disorders, self-injury, and a fascination with water.

Behavioral therapy may be able to help address and cope with these issues.

In communication therapy, speech and language therapists should be involved from an early stage to assess speech development in the child and help identify what approaches will benefit them the most.

Occupational therapy focuses on developing specific skills that can help the children perform daily activities and improve their social interaction.

Physiotherapy can identify problem areas and introduce a tailored exercise plan that can, for example, improve motor skills, strength, posture, and balance.

By Drug Type:

On the basis of drug type, the China Angelman syndrome therapeutics market can be segmented into antiepileptic drugs and anticonvulsant drugs.

Epilepsy is commonly associated with Angelman syndrome, causing seizures, jerky movements, and prolonged periods of unresponsiveness known as nonconvulsive status epilepticus (NCSE). Antiepileptic drugs include Sodium Valproate, Clonazepam and Topiramate are used to treat Angelman syndrome associated epilepsy. Anticonvulsant drugs such as Phenobarbital are used for treatment of Angelman syndrome.

By Distribution Channel:

On the basis of distribution channel, the China Angelman syndrome therapeutics market can be segmented into retail, online and hospital pharmacies. During the forecast period (2020-2028) hospital pharmacies are the key distribution channels as they have a large patient base compared to other healthcare facilities and they also conduct various clinical trials. Second largest distribution channel is retail pharmacies as for the symptomatic treatment drugs are available in retail pharmacies.

 

Major Players

Some of the key players in the China Angelman syndrome therapeutics market are Ovid Therapeutics Inc; Hong Kong Angelman Syndrome Foundation (HKASF); H. Lundbeck A/S; Sarepta Therapeutics.

Key players are adapting various strategies such as distribution partnership, collaboration and licensing agreement to increase the product awareness and market share of the product. For instance, Lundbeck and Ovid Therapeutics Announce Exclusive Worldwide Licensing Agreement for Gaboxadol, and it is used for treatment of Angelman syndrome.

The China Angelman Syndrome Therapeutics Market report is an easy-to-understand document giving section-wise details about the global market. Starting with the brief outline of the overall market, it will put forth the all-inclusive evaluated market statistics and different parameters for the forecast period. The report covers numerous aspects of the China Angelman Syndrome Therapeutics market divided into product kind, application, and end-use, offering the report to assist the customers in improving their ability to make precise decisions related to the business under the China Angelman Syndrome Therapeutics Market.

International Market Players will use the correct market facts and figures and applied math studies provided within the report back to perceive this and future growth of the worldwide Electrophoretic China Angelman Syndrome Therapeutics market. Each section of the research study is specially prepared to explore key aspects of the global China Angelman Syndrome Therapeutics Market. Buyers of the report will have access to accurate PESTLE, SWOT, and other types of analysis on the global China Angelman Syndrome Therapeutics market. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries.

This post-pandemic business planning research will aid clients to:
• Adjust their strategic planning to move ahead once business stability kicks in.
• Build resilience by making effective resource and investment choices for individual business units, products, and service lines.
• Conceptualize scenario-based planning to mitigate future crisis situations.

Instant Buy This Report and Get Up To 40% Discount [Use Corporate Email ID]: https://www.prudentmarkets.com/discount-request/139809/

Get full copy of 225+ pages research report (Inclusion of updated research on COVID-19) on United States Region at $1500 and, Europe region at $2000. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Our qualified team of researchers, analysts, and consultants use in-depth qualitative research, quantitative research, and the latest recognized research techniques to offer an unrivaled level of detail and value to your research activities. Our market and competitive intelligence can be utilized by teams across multiple departments, including sales and business development, marketing, to:

• Access the latest information on potential competitors and customers through a comprehensive database
• Analyse the business strategies and collaborations of multiple companies within a specific market
• Identify new markets and regions for future expansion
• Compare financial trends between competitor companies
• Get to know about mergers and acquisitions
• Explore the strengths and weaknesses of companies cross-industry
• Improve your business modeling

Strategic Points Covered in Table of Content of Global China Angelman Syndrome Therapeutics Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the China Angelman Syndrome Therapeutics market
Chapter 2: Exclusive Summary - the basic information of the China Angelman Syndrome Therapeutics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the China Angelman Syndrome Therapeutics
Chapter 4: Presenting the China Angelman Syndrome Therapeutics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the China Angelman Syndrome Therapeutics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

(If you have any special requirements, please let us know and we will offer you the report as you want.)

Inquire Before Purchasing The Complete Report To Grow Your Business: https://www.prudentmarkets.com/enquiry-request/139809/

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.